Literature DB >> 20720108

Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase.

Li-Jin Chew1, William Coley, Ying Cheng, Vittorio Gallo.   

Abstract

Many extracellular and intrinsic factors regulate oligodendrocyte development, but their signaling pathways remain poorly understood. Although the p38 mitogen-activated protein kinase (MAPK)-dependent pathway is implicated in oligodendrocyte progenitor cell (OPC) lineage progression, its molecular targets involved in myelinogenesis are mostly unidentified. We have analyzed mechanisms by which p38MAPK regulates oligodendrocyte development and demonstrate that p38MAPK inhibition prevents OPC lineage progression and inhibits MBP (myelin basic protein) promoter activity and Sox10 function. In white-matter tissue, differential levels of MAPK phosphorylation are observed in oligodendrocyte lineage cells. Phosphorylated p38MAPK was found in CC1- and CNP-expressing differentiated oligodendrocytes of the adult brain and was temporally associated with a decline in the levels of phosphorylated extracellular signal-regulated kinase (ERK) in cells of this lineage. PDGF stimulates the phosphorylation of ERK, p38MAPK, and c-Jun N-terminal kinase (JNK), and p38MAPK inhibition was associated with increased ERK, JNK, and c-Jun phosphorylation. In the presence of PDGF, simultaneous inhibition of p38MAPK and either MAPK kinase (MEK) or JNK significantly alleviates the repression of myelin gene expression and lineage progression induced by p38MAPK inhibition alone. Dominant-negative c-Jun reverses the inhibition of myelin promoter activity by active MEK1 or dominant-negative p38MAPKalpha mutants, and phosphorylated c-Jun was detected at the MBP promoter after p38MAPK inhibition, indicating c-Jun as a negative mediator of p38MAPK action. Our findings indicate that p38MAPK activity in the brain supports myelin gene expression through distinct mechanisms via positive and negative regulatory targets. We show that oligodendrocyte differentiation involves p38-mediated Sox10 regulation and cross talk with parallel ERK and JNK pathways to repress c-Jun activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720108      PMCID: PMC3327889          DOI: 10.1523/JNEUROSCI.2546-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  88 in total

1.  A role for an AP-1-like site in the expression of the myelin basic protein gene during differentiation.

Authors:  R Miskimins; W K Miskimins
Journal:  Int J Dev Neurosci       Date:  2001-02       Impact factor: 2.457

2.  p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target.

Authors:  Narayan R Bhat; Peisheng Zhang; Sangeeta B Mohanty
Journal:  Neurochem Res       Date:  2007-01-19       Impact factor: 3.996

3.  MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells.

Authors:  Makoto Horiuchi; Aki Itoh; David Pleasure; Takayuki Itoh
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

4.  Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte progenitor cells.

Authors:  Li-Jin Chew; William C King; Ann Kennedy; Vittorio Gallo
Journal:  Glia       Date:  2005-11-01       Impact factor: 7.452

5.  Identification of Sox17 as a transcription factor that regulates oligodendrocyte development.

Authors:  Jiho Sohn; JoAnne Natale; Li-Jin Chew; Shibeshih Belachew; Ying Cheng; Adan Aguirre; Judith Lytle; Brahim Nait-Oumesmar; Christophe Kerninon; Masami Kanai-Azuma; Yoshiakira Kanai; Vittorio Gallo
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

6.  Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation.

Authors:  Ren Zhang; Shunichi Murakami; Françoise Coustry; Ying Wang; Benoit de Crombrugghe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

7.  p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway.

Authors:  Lijian Hui; Latifa Bakiri; Andreas Mairhorfer; Norbert Schweifer; Christian Haslinger; Lukas Kenner; Vukoslav Komnenovic; Harald Scheuch; Hartmut Beug; Erwin F Wagner
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

8.  Inhibition of p38 mitogen-activated protein kinase enhances c-Jun N-terminal kinase activity: implication in inducible nitric oxide synthase expression.

Authors:  Aleksi Lahti; Outi Sareila; Hannu Kankaanranta; Eeva Moilanen
Journal:  BMC Pharmacol       Date:  2006-02-21

9.  p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation.

Authors:  Juan José Ventura; Stephan Tenbaum; Eusebio Perdiguero; Marion Huth; Carmen Guerra; Mariano Barbacid; Manolis Pasparakis; Angel R Nebreda
Journal:  Nat Genet       Date:  2007-04-29       Impact factor: 38.330

10.  The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors.

Authors:  Sandra Wissmüller; Thomas Kosian; Michael Wolf; Markus Finzsch; Michael Wegner
Journal:  Nucleic Acids Res       Date:  2006-03-31       Impact factor: 16.971

View more
  47 in total

1.  SRY-box containing gene 17 regulates the Wnt/β-catenin signaling pathway in oligodendrocyte progenitor cells.

Authors:  Li-Jin Chew; Weiping Shen; Xiaotian Ming; Vladimir V Senatorov; Hui-Ling Chen; Ying Cheng; Elim Hong; Susan Knoblach; Vittorio Gallo
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  Diazoxide promotes oligodendrocyte differentiation in neonatal brain in normoxia and chronic sublethal hypoxia.

Authors:  Ying Zhu; Christopher C Wendler; Olivia Shi; Scott A Rivkees
Journal:  Brain Res       Date:  2014-08-23       Impact factor: 3.252

Review 3.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 4.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

5.  Specific functions for ERK/MAPK signaling during PNS development.

Authors:  Jason M Newbern; Xiaoyan Li; Sarah E Shoemaker; Jiang Zhou; Jian Zhong; Yaohong Wu; Daniel Bonder; Steven Hollenback; Giovanni Coppola; Daniel H Geschwind; Gary E Landreth; William D Snider
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

6.  Chromatin landscape defined by repressive histone methylation during oligodendrocyte differentiation.

Authors:  Jia Liu; Laura Magri; Fan Zhang; Nidaa O Marsh; Stefanie Albrecht; Jimmy L Huynh; Jasbir Kaur; Tanja Kuhlmann; Weijia Zhang; Paul A Slesinger; Patrizia Casaccia
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

7.  p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination.

Authors:  David P Yang; Jihyun Kim; Neeraja Syed; Young-John Tung; Ambily Bhaskaran; Thomas Mindos; Rhona Mirsky; Kristjan R Jessen; Patrice Maurel; David B Parkinson; Haesun A Kim
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

Review 8.  Zebrafish as a model to investigate CNS myelination.

Authors:  Marnie A Preston; Wendy B Macklin
Journal:  Glia       Date:  2014-09-27       Impact factor: 7.452

9.  Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation.

Authors:  Yan Yang; Haibo Wang; Jie Zhang; Fucheng Luo; Karl Herrup; James A Bibb; Richard Lu; Robert H Miller
Journal:  Dev Biol       Date:  2013-04-10       Impact factor: 3.582

10.  Thymosin β 4 mediates oligodendrocyte differentiation by upregulating p38 MAPK.

Authors:  Manoranjan Santra; Michael Chopp; Zheng Gang Zhang; Mei Lu; Sutapa Santra; Ankita Nalani; Soumi Santra; Daniel C Morris
Journal:  Glia       Date:  2012-08-01       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.